Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Change in Acquisitions & Divestments (2019 - 2025)

Korro Bio (KRRO) has disclosed Change in Acquisitions & Divestments for 6 consecutive years, with $22.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Acquisitions & Divestments rose 62.85% year-over-year to $22.8 million, compared with a TTM value of $82.6 million through Sep 2025, up 490.0%, and an annual FY2024 reading of $40.9 million, up 115.26% over the prior year.
  • Change in Acquisitions & Divestments was $22.8 million for Q3 2025 at Korro Bio, up from $1000.0 in the prior quarter.
  • Across five years, Change in Acquisitions & Divestments topped out at $32.9 million in Q1 2025 and bottomed at $1000.0 in Q2 2025.
  • Average Change in Acquisitions & Divestments over 5 years is $13.2 million, with a median of $14.0 million recorded in 2024.
  • The sharpest move saw Change in Acquisitions & Divestments skyrocketed 94475.0% in 2021, then crashed 99.86% in 2022.
  • Year by year, Change in Acquisitions & Divestments stood at $11.6 million in 2021, then plummeted by 99.86% to $16000.0 in 2022, then surged by 6150.0% to $1.0 million in 2023, then skyrocketed by 2590.0% to $26.9 million in 2024, then dropped by 15.25% to $22.8 million in 2025.
  • Business Quant data shows Change in Acquisitions & Divestments for KRRO at $22.8 million in Q3 2025, $1000.0 in Q2 2025, and $32.9 million in Q1 2025.